(WASHINGTON)Teva Pharmaceutical Industries Ltd. and its acquisition target Barr Pharmaceuticals demonstrated the earnings power of generic drugs Thursday amid a serious economic slowdown.READ MORE

(NEW YORK)Generic drugmaker Teva Pharmaceutical Industries Ltd. said Thursday the company's profits rose 20 percent in the third quarter on higher sales of its low-cost generic medications a...READ MORE

(NEW YORK)Barr Pharmaceuticals Inc. forecast a full-year profit mostly above Wall Street estimates Thursday, and its 2008 revenue outlook is also slightly above analyst expectations.READ MORE

(MONTVALE, N.J.)Barr Pharmaceuticals Inc. said Thursday its profit shrank 21 percent in the third quarter, as greater costs counteracted rising sales of its generic birth control pills.READ MORE

(MONTVALE, N.J.)Generic drug developer Barr Pharmaceuticals Inc. said Monday its Pliva-Lachema subsidiary received Food and Drug Administration approval for a generic version of Pfizer Inc.'s colo...READ MORE

(MONTVALE, N.J.)Regulators have approved Barr Pharmaceuticals Inc.'s low-dose contraceptive LoSeasonique, the company said Monday, and Barr plans to begin selling the drug in the first quarter of ...READ MORE

(CORONA, Calif.)Watson Pharmaceuticals Inc. is suing Barr Pharmaceuticals Inc. to prevent Barr from selling a generic version of the Oxytrol overactive bladder patch, Watson said Friday.READ MORE